title: [Contrast-enhanced endoscopic ultrasound in the diagnosis of pancreatic diseases].
abstract: The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) recently introduced guidelines on the use of contrast enhanced ultrasound (CEUS). The so-called non-liver guidelines included clinical recommendations on the use of CEUS in pancreatic diseases. This article focuses on the application of endoscopic ultrasound in the evaluation of pancreatic neoplasia to highlight the importance of CEUS in daily routine.
authors.affiliation: Klinikum Meiningen GmbH, Meiningen. Michael.hocke@klinikum-meiningen.de
authors.forename: M
authors.initials: M
authors.lastname: Hocke
authors.forename: C F
authors.initials: CF
authors.lastname: Dietrich
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000473:pathology; D003287:Contrast Media / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D019160:Endosonography / Q000379:methods*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000556:secondary; D010192:Pancreatic Pseudocyst / Q000000981:diagnostic imaging; D050500:Pancreatitis, Chronic / Q000000981:diagnostic imaging* / Q000473:pathology; D018608:Ultrasonography, Doppler
chemical_list: D003287:Contrast Media